670 related articles for article (PubMed ID: 21972252)
1. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.
Musselman ME; Browning LA; Parker D; Saely S
Ann Pharmacother; 2011 Nov; 45(11):e61. PubMed ID: 21972252
[TBL] [Abstract][Full Text] [Related]
2. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
Borovicka MC; Bond LC; Gaughan KM
Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
[TBL] [Abstract][Full Text] [Related]
3. Suspected neuroleptic malignant syndrome in a patient receiving clozapine.
Ganelin L; Lichtenberg PS; Marcus EL; Munter RG
Ann Pharmacother; 1996 Mar; 30(3):248-50. PubMed ID: 8833560
[TBL] [Abstract][Full Text] [Related]
4. Fluphenazine-induced neuroleptic malignant syndrome in a schizophrenic patient.
Aruna AS; Murungi JH
Ann Pharmacother; 2005 Jun; 39(6):1131-5. PubMed ID: 15840734
[TBL] [Abstract][Full Text] [Related]
5. Olanzapine-associated neuroleptic malignant syndrome in a patient receiving concomitant rivastigmine therapy.
Stevens DL; Lee MR; Padua Y
Pharmacotherapy; 2008 Mar; 28(3):403-5. PubMed ID: 18294120
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic malignant syndrome associated with olanzapine.
Filice GA; McDougall BC; Ercan-Fang N; Billington CJ
Ann Pharmacother; 1998 Nov; 32(11):1158-9. PubMed ID: 9825080
[TBL] [Abstract][Full Text] [Related]
7. Neuroleptic malignant syndrome secondary to quetiapine.
Gortney JS; Fagan A; Kissack JC
Ann Pharmacother; 2009 Apr; 43(4):785-91. PubMed ID: 19299325
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine-associated neuroleptic malignant syndrome.
Norgard NB; Stark JE
Pharmacotherapy; 2006 Aug; 26(8):1180-2. PubMed ID: 16863495
[TBL] [Abstract][Full Text] [Related]
9. Prochlorperazine-induced neuroleptic malignant syndrome.
Tee ZJ
Am J Emerg Med; 2024 Jul; 81():160.e1-160.e2. PubMed ID: 38575461
[TBL] [Abstract][Full Text] [Related]
10. Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia.
Srivastava A; Borkar HA; Chandak S
Psychiatry Clin Neurosci; 2009 Feb; 63(1):119-21. PubMed ID: 19067992
[TBL] [Abstract][Full Text] [Related]
11. [Clozapine-associated neuroleptic malignant syndrome followed by catatonia: a case report].
Erol A; Putgül G; Sert E; Mete L
Turk Psikiyatri Derg; 2013; 24(2):140-4. PubMed ID: 23754268
[TBL] [Abstract][Full Text] [Related]
12. Atypical neuroleptic malignant syndrome caused by olanzapine.
Nielsen J; Bruhn AM
Acta Psychiatr Scand; 2005 Sep; 112(3):238-40; discussion 240. PubMed ID: 16095481
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic malignant syndrome during a change from haloperidol to risperidone.
Reeves RR; Mack JE; Torres RA
Ann Pharmacother; 2001 Jun; 35(6):698-701. PubMed ID: 11408988
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic malignant syndrome secondary to aripiprazole initiation in a clozapine-intolerant patient.
Patel MK; Brunetti L
Am J Health Syst Pharm; 2010 Aug; 67(15):1254-9. PubMed ID: 20651315
[TBL] [Abstract][Full Text] [Related]
15. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
16. Neuroleptic malignant syndrome and clozapine.
Reddig S; Minnema AM; Tandon R
Ann Clin Psychiatry; 1993 Mar; 5(1):25-7. PubMed ID: 8102300
[TBL] [Abstract][Full Text] [Related]
17. Neuroleptic malignant syndrome due to olanzapine.
Hall KL; Taylor WH; Ware MR
Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
[TBL] [Abstract][Full Text] [Related]
18. [Neuroleptic malignant syndrome after treatment with olanzapine].
Emborg C
Ugeskr Laeger; 1999 Mar; 161(10):1424-5. PubMed ID: 10085753
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.
Aboraya A; Schumacher J; Abdalla E; LePage J; McGhee M; Butcher D; Griffin H; Shahda M
W V Med J; 2002; 98(2):63-5. PubMed ID: 12048741
[TBL] [Abstract][Full Text] [Related]
20. Olanzapine induced neuroleptic malignant syndrome--a case review.
Kogoj A; Velikonja I
Hum Psychopharmacol; 2003 Jun; 18(4):301-9. PubMed ID: 12766935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
